Additional terms and conditions may apply.
Please see reverse side of the invoice or packing slip.
AL-249
Aldrich Sure/Pac Station Instructions
Station for Non-Corrosive Liquefi ed Gases, Brass Regulator
-20 ng/ml as measured by its monocyte chemotactic activity.
Purity: ≥97% by SDS-PAGE.
10 mg € 249
Oncostatin M, Human, Recombinant, E. coli 496260 Biological activity: ED50 = 0.15-0.30 ng/ml as
cell-permeable, potent, selective, and irreversible inhibitor
of CDC25 family phosphatases (IC50 = 109, 160, 249, 201, and
117 nM for 25A, 25B2, 25B3, 25C, and 25C-cat, respectively).
Purity: ≥98% by HPLC. M.W.
ELISA FC IH R IgG2a 250 µg MAB3129-250UG $650
Bim-GST WB KA 100 µg 12-483 $275
Bim-GST (3A) WB KA 100 µg 12-484 $275
Anti-phospho-Bim EL (Ser69) H R WB Rb 100 µL AB3579
to disintegrate.
• In a volumetric flask dilute 2 ml of beer with H2O to make 500 ml (dilution 1 + 249).
33.6 Procedure and measurement
User-defined calibration:
• Prepare standard solutions in the
to disintegrate.
• In a volumetric flask dilute 2 ml of beer with H2O to make 500 ml (dilution 1 + 249).
33.6 Procedure and measurement
User-defined calibration:
• Prepare standard solutions in the
to disintegrate.
• In a volumetric flask dilute 2 ml of beer with H2O to make 500 ml (dilution 1 + 249).
33.6 Procedure and measurement
User-defined calibration:
• Prepare standard solutions in the
to disintegrate.
• In a volumetric flask dilute 2 ml of beer with H2O to make 500 ml (dilution 1 + 249).
33.6 Procedure and measurement
User-defined calibration:
• Prepare standard solutions in the
Webb, K. Tissue engineering therapies for
the vocal fold lamina propria. Tissue Eng Part B Rev 15,
249, 2009.
11. Fiegel, H.C., et al. Hepatic tissue engineering: from trans-
plantation to customized
120–125.
19. Bensadoun, A., Ehnholm, C., Steinberg,
D., and Brown, W. V. (1974) J. Biol.
Chem. 249, 2220–2227.
20. Slutzky, G. M. and Ji, T. H. (1974)
Biochim. Biophys. Acta 373, 337–346.
21.
Mapk7,MAPK7 NP_035971.1,NP_620603.1 P y y n/d
248 Elastin E4013 2006 ELN NP_001075224.1 M y n/d n/d
249 ELKS E4531 111173, 23085 Erc1,ERC1 NP_835186.1,NP_829884.1 M y y y
250 Endothelial Cell Protein C Receptor
Mapk7,MAPK7 NP_035971.1,NP_620603.1 P y y n/d
248 Elastin E4013 2006 ELN NP_001075224.1 M y n/d n/d
249 ELKS E4531 111173, 23085 Erc1,ERC1 NP_835186.1,NP_829884.1 M y y y
250 Endothelial Cell Protein C Receptor
SAPK2b2, active KA 10 µg 14-253
p38γ/SAPK3, active KA 10 µg 14-246
p38δ/SAPK4, active KA 10 µg 14-249
siRNA
siRNA plasmid, pKD-p38α/SAPK2a-v1 H RNAi 5 µg 62-294
siRNA plasmid, pKD-p38α/SAPK2a-
Tong, W.M., et al. 2001. Biochim. Biophys. Acta 1552, 27.
DíAmours, D., et al. 1999. Biochem. J. 342, 249.
Shieh, W.M., et al. 1998. J. Biol. Chem. 273, 30069.
Mazen, A., et al. 1989. Nucleic Acids Res. 17